Nanomaterials have been extensively studied in cancer therapy as vectors that may improve
drug delivery. Such vectors not only bring numerous advantages such as stability …

The immune system has to cope with a wide range of irregularly shaped pathogens that can
actively move (eg, by flagella) and also dynamically remodel their shape (eg, transition from …

The widespread use of biomaterials to support or replace body parts is increasingly
threatened by the risk of implant‐associated infections. In the quest for finding novel anti …

Targeted drug delivery refers to an established therapeutic strategy that develops platforms
and nanoscale devices for selective delivery of small drug molecules and therapeutic genes …

Antiviral activities of antibodies may either be dependent only on interactions between the
antibody and cognate antigen, as in binding and neutralization of an infectious virion, or …

Microrobots offer transformative solutions for non‐invasive medical interventions due to their
small size and untethered operation inside the human body. However, they must face the …

Intravascular drug delivery technologies majorly utilize spherical nanoparticles as carrier
vehicles. Their targets are often at the blood vessel wall or in the tissue beyond the wall …

Nanoparticles (NPs) are functionalized with targeting ligands to enable selectively delivering
drugs to desired locations in the body. When these functionalized NPs enter the blood …

Long acting injectable formulations have been developed to sustain the action of drugs in
the body over desired periods of time. These delivery platforms have been utilized for both …

Encapsulation of therapeutic agents in nanoparticles offers several benefits including
improved bioavailability, site specific delivery, reduced toxicity and in vivo stability of …